Prestige Biologics Co Ltd
KOSDAQ:334970
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cheniere Energy Inc
LSE:0HWH
|
US |
|
SMA Solar Technology AG
XETRA:S92
|
DE |
|
Brightsphere Investment Group Inc
NYSE:BSIG
|
US |
Prestige Biologics Co Ltd
EPS (Diluted)
Prestige Biologics Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Prestige Biologics Co Ltd
KOSDAQ:334970
|
EPS (Diluted)
-₩363
|
CAGR 3-Years
28%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
EPS (Diluted)
₩4.7k
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
17%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
EPS (Diluted)
-₩800
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
EPS (Diluted)
-₩1.9k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
EPS (Diluted)
₩2.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
55%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
EPS (Diluted)
-₩734
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Prestige Biologics Co Ltd
Glance View
Prestige Biologics Co., Ltd. engages in research, development, and supplying of pharmaceutical products. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 199 full-time employees. The company went IPO on 2021-03-11. The firm mainly engages in the contract manufacturing service business that produces and supplies biopharmaceuticals; and contract development service business that provides development services including cell culture process and purification process.
See Also
What is Prestige Biologics Co Ltd's EPS (Diluted)?
EPS (Diluted)
-363.1
KRW
Based on the financial report for Dec 31, 2025, Prestige Biologics Co Ltd's EPS (Diluted) amounts to -363.1 KRW.
What is Prestige Biologics Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
16%
Over the last year, the EPS (Diluted) growth was 32%. The average annual EPS (Diluted) growth rates for Prestige Biologics Co Ltd have been 28% over the past three years , 16% over the past five years .
